130 related articles for article (PubMed ID: 34333946)
1. [Preliminary efficacy and safety analysis of carrelizumab combined with apatinib in patients with middle-advanced liver cancer progressed after drug-eluting beads-transcatheter arterial chemoembolization].
Liu J; Cao G; Zhang GS; Xu WJ; Liu SY; Shi DQ
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(29):2304-2309. PubMed ID: 34333946
[No Abstract] [Full Text] [Related]
2. Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: A single-center randomized controlled trial.
Lu W; Jin XL; Yang C; Du P; Jiang FQ; Ma JP; Yang J; Xie P; Zhang Z
Cancer Biol Ther; 2017 Jun; 18(6):433-438. PubMed ID: 28548587
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter arterial chemoembolization combined with low-dose apatinib in the treatment of unresectable hepatocellular carcinoma in elderly patients: Efficacy and safety.
Liu S; Zhao G; Yu G; Guo N; Zhang Y; Li Q; Wang Z
J Cancer Res Ther; 2020 Sep; 16(5):1165-1170. PubMed ID: 33004765
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma.
Liu J; Xu J; Zhang W; Chen J; Zhou X; Li Z; Han X
Acad Radiol; 2020 May; 27(5):704-709. PubMed ID: 31375353
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma.
Li Z; Chen Q; Zhang W; Si G; Li J; Jiao D; Han X
Can J Gastroenterol Hepatol; 2021; 2021():5565793. PubMed ID: 34458205
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study.
Yang Z; Chen G; Cui Y; Xiao G; Su T; Yu J; Zhang Z; Han Y; Yang K; Jin L
Cancer Biol Ther; 2019; 20(3):321-327. PubMed ID: 30332553
[TBL] [Abstract][Full Text] [Related]
7. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
[TBL] [Abstract][Full Text] [Related]
8. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
[TBL] [Abstract][Full Text] [Related]
9. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus.
Zhang W; Wu L; Chen L; Sun T; Ren Y; Sun B; Zhu L; Han P; Zheng C
Sci Rep; 2022 Apr; 12(1):5725. PubMed ID: 35388064
[TBL] [Abstract][Full Text] [Related]
11. Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma.
Liu J; Xie S; Duan X; Chen J; Zhou X; Li Y; Li Z; Han X
Cancer Chemother Pharmacol; 2020 Jan; 85(1):69-76. PubMed ID: 31813003
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of TACE combined with Apatinib in the treatment of advanced hepatocellular carcinoma.
Zhu Y; Feng B; Mei L; Sun R; Guo C; Zhu J
J BUON; 2019; 24(2):608-614. PubMed ID: 31128013
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of apatinib and transcatheter arterial chemoembolization as second-line therapy for advanced hepatocellular carcinoma: A retrospective cohort study.
Li T; Zhao J; Zhang S; Wang H; Sun L; Hu J
J Cancer Res Ther; 2023 Feb; 19(1):57-63. PubMed ID: 37006043
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of aparatinib and carrilizumab combined with transcatheter arterial chemoembolization in the treatment of primary hepatocellular carcinoma.
Chen C; Duan XT; Li GY; Hao XJ; Wang WL; Shen YF; Zhang SH
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4135-4144. PubMed ID: 37203839
[TBL] [Abstract][Full Text] [Related]
15. Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety.
Zhang ZS; Li HZ; Ma C; Xiao YD
BMC Cancer; 2019 Nov; 19(1):1162. PubMed ID: 31783814
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
17. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
18. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of the Combination of Transarterial Chemoembolization with Camrelizumab plus Apatinib for Advanced Hepatocellular Carcinoma: A Retrospective Study of 38 Patients from a Single Center.
Zhang JX; Chen YX; Zhou CG; Liu J; Liu S; Shi HB; Zu QQ
Can J Gastroenterol Hepatol; 2022; 2022():7982118. PubMed ID: 35586608
[TBL] [Abstract][Full Text] [Related]
20. Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review.
Kou P; Zhang Y; Shao W; Zhu H; Zhang J; Wang H; Kong L; Yu J
Oncotarget; 2017 Mar; 8(12):20510-20515. PubMed ID: 28103584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
